al101
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 14, 2019 (NCT04111666)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04973683 | Phase 1 | Sep 30, 2021 | University of Texas at Houston |
| NCT04461600 | Phase 2 | Aug 14, 2020 | Ayala Pharmaceuticals, Inc, |
| NCT04111666 | Phase 1 | Dec 14, 2019 | Alector Inc., BioClinica, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alector Inc. | For profit | 1 | 1 | 1 | 2019 |
| Ayala Pharmaceuticals, Inc, | For profit | 1 | 1 | 1 | 2020 |
| BioClinica, Inc. | For profit | 1 | 0 | 1 | 2019 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2021 |
4 organizations
Page 1 / 1